Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting SystemmedRxiv · 2026-09-10Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.European journal of pharmacology · 2026-09-10Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use DisordersCurrent Addiction Reports · 2026-09-02High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialClinicalTrials.gov · 2026-09-02AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression.Journal of managed care & specialty pharmacy · 2026-09-01Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-09-01NeuroGuard: Psilocybin Trial for Preventing Chemo-induced NeuropathyClinicalTrials.gov · 2026-08-31“Am I a candidate for magic mushrooms?” A mystery shopper study of Oregon psilocybin service centersHealth Affairs Scholar · 2026-08-27Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation servicemedRxiv · 2026-08-19Psychedelics align brain activity with context.Nature · 2026-08-19An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)ClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.Psychology and psychotherapy · 2026-08-10Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06One Dose of Psilocybin May Alter Brain StructurePsychiatric News · 2026-08-01Cardiovascular safety of psilocybin in psychiatric practice: a narrative reviewEuropean Journal of Clinical Pharmacology · 2026-08-01Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depressionPharmacological Research · 2026-08-01A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosisFrontiers in Public Health · 2026-07-20Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.Molecular psychiatry · 2026-07-16Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open MIND · 2026-07-09Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-05Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research DirectionsInternational Journal of Eating Disorders · 2026-07-02Recreational drug poisonings reported to six European poison centres from 2021 to 2024.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.Nature communications · 2026-06-24Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-06-23Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyClinicalTrials.gov · 2026-06-22Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic ReviewCNS Drugs · 2026-06-14Altered States, Enhanced Potential: Psychedelics and Physical PerformancePsyArXiv · 2026-06-12Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-09Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-02Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network AnalysisJournal of Pain and Symptom Management · 2026-06-01Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-01Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Molecular psychiatry · 2026-05-29Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorderTranslational Psychiatry · 2026-05-26PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-21Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.Neuroscience bulletin · 2026-05-210408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart StudySLEEPJ · 2026-05-08Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Human brain changes after first psilocybin useNature Communications · 2026-05-05PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.The British journal of psychiatry: the journal of mental science · 2026-05-01High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01Landscape analysis of pre-registered clinical trials involving classical psychedelics.Journal of psychopharmacology (Oxford, England) · 2026-05-01Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain modelsStanford Digital Repository · 2026-04-30The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum DisorderPreprints.org · 2026-04-29The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-21Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled TrialsOpen Access Indonesian Journal of Medical Reviews · 2026-04-21Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-18Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-17Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-17Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe MushroomsScience Letters · 2026-04-17Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-15Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.Acta neuropsychiatrica · 2026-04-10Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal HypnotherapyPreprints.org · 2026-04-07Psilocybin and human longevitynpj Aging · 2026-04-03Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.Biotechnology and bioengineering · 2026-04-01Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”PsyArXiv · 2026-03-30Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-30Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-28Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronseLife · 2026-03-27Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled TrialPsyArXiv · 2026-03-26Integrated 5-HT -TrkB and G protein signaling in serotonergic psychedelic responses.bioRxiv: the preprint server for biology · 2026-03-23Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military PersonnelJournal of Police and Criminal Psychology · 2026-03-22Psychedelics in functional disorders: A scoping review.Progress in neuro-psychopharmacology & biological psychiatry · 2026-03-20Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).Journal of psychoactive drugs · 2026-03-16Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-03-01The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-03-01Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-25Psychedelic medicine: mechanisms, evidence, and translation to practice.BMJ (Clinical research ed.) · 2026-02-23Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.Neuropharmacology · 2026-02-15Compassionate use of psilocybin for treatment-resistant depression in Germany.The lancet. Psychiatry · 2026-02-01Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.Neuropharmacology · 2026-02-01Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.Brain and behavior · 2026-02-01We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.ChemMedChem · 2026-02-01No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain.Nature communications · 2026-01-22Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-16Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsResearch Square · 2026-01-07COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01Electrical brain changes following psilocybin administration in sprague-dawley ratsNeuroscience Applied · 2026-01-01Psilocybin Treatment for Refractory Depression: A Clinical ReviewDigital Commons - Gardner-Webb University (Gardner-Webb University) · 2026-01-01Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.Journal of addiction medicine · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.Journal of neuroscience research · 2026-01-01The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationClinicalTrials.gov · 2025-12-24A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-23The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-22Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot StudyJournal of Complementary and Alternative Medical Research · 2025-12-16Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and CodependencyContemporary Family Therapy · 2025-12-11Are Magic Mushrooms the Magic to Healing?DigitalCommons - Kennesaw State University (Kennesaw State University) · 2025-12-07Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvementResearch Square · 2025-12-01Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-12-01Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical sciences (Basel, Switzerland) · 2025-11-20Psilocybin Experiential Therapist Training: Insights from a World-First StudymedRxiv · 2025-11-17Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.Angewandte Chemie (International ed. in English) · 2025-11-10The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.Journal of psychoactive drugs · 2025-11-09Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-11-01[Acceptance of psilocybin-assisted therapy in German-speaking countries].Der Nervenarzt · 2025-11-01Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.Schizophrenia bulletin · 2025-10-06Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases.Nordic journal of psychiatry · 2025-10-01Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01Unterschiedliche Reaktionen und Enzyme in der Psilocybin- Biosynthese bei Inocybe- und Psilocybe -PilzenAngewandte Chemie · 2025-09-21Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.Addiction (Abingdon, England) · 2025-09-20Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.Acta neuropsychiatrica · 2025-09-03Active Constituents of Psilocybin Mushroom Edibles.JAMA network open · 2025-09-02Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-09-01Psilocybin biosynthesis enhancement through gene source optimization.Metabolic engineering · 2025-09-01Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and RatsBiological Psychiatry Global Open Science · 2025-09-01Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder AnalysisResearch Square · 2025-08-19317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATSThe international journal of neuropsychopharmacology · 2025-08-01363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIORThe international journal of neuropsychopharmacology · 2025-08-01Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.Neuroscience and biobehavioral reviews · 2025-08-01Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.Fundamental & clinical pharmacology · 2025-08-01204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDERThe International Journal of Neuropsychopharmacology · 2025-07-31551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHESThe International Journal of Neuropsychopharmacology · 2025-07-31Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use DisorderbioRxiv · 2025-07-18Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention StudiesWellcome Open Res · 2025-07-08Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models.bioRxiv: the preprint server for biology · 2025-07-07Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-07-01The Rise of Psilocybin Use in the United States: A Multisource Observational Study.Annals of internal medicine · 2025-07-01Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted TherapyArchiv der Pharmazie · 2025-07-01Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.Current oncology (Toronto, Ont.) · 2025-06-30Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-18Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-10ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.European journal of anaesthesiology · 2025-05-01Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.Drug safety · 2025-05-01Psilocybin for disorders of consciousness: A case-report study.Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology · 2025-05-010391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart StudySLEEP · 2025-04-30Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-04-10Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.Biology direct · 2025-04-10458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene ExpressionBiological Psychiatry · 2025-04-0913. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic PainJournal of Pain · 2025-04-01From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice.Pharmacology research & perspectives · 2025-04-01Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-29Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their ImplicationsPharmaceuticals · 2025-03-07Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)Journal of Pharmacology and Experimental Therapeutics · 2025-03-01Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.Molecular psychiatry · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online samplePsyArXiv · 2025-02-28Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online samplePsyArXiv · 2025-02-28Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.BMC psychiatry · 2025-02-28Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-13Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-12Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology.bioRxiv: the preprint server for biology · 2025-02-11Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-06The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.Medicina (Kaunas, Lithuania) · 2025-02-06Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitionersJournal of Psychedelic Studies · 2025-02-05International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-02-01Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal SurveyDrug and Alcohol Dependence · 2025-02-01BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODELThe international journal of neuropsychopharmacology · 2025-02-01ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDERThe international journal of neuropsychopharmacology · 2025-02-01Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.FEBS letters · 2025-02-01From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).Scientific reports · 2025-01-29PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERSHealth and Society · 2025-01-08Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2025-01-01Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2025-01-01Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.Journal of psychoactive drugs · 2025-01-01Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.Annual review of medicine · 2025-01-01Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.The American journal of psychiatry · 2025-01-01Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.The American journal of psychiatry · 2025-01-01Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.Clinical neuropharmacology · 2025-01-01Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.International journal of medicinal mushrooms · 2025-01-01Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.PloS one · 2025-01-01